# Syremis Therapeutics

**Canonical:** https://apis.io/providers/syremis-therapeutics/  
**Website:** https://syremis.com  
**APIs profiled:** 0

Syremis Therapeutics is a clinical-stage biopharmaceutical company based in Tel Aviv, Israel and Boston, Massachusetts, developing best-in-class oral small-molecule medicines for serious mental health conditions. Its neuropsychiatric pipeline is rooted in clinically validated mechanisms including muscarinic M1/M4 agonism and next-generation NMDA antagonism; lead program ST-905 is a dual M1/M4 agonist in Phase 1 for schizophrenia, with ST-901 also spun out from Clexio Biosciences. The company launched publicly in December 2025 with a $165M Series A co-led by Dexcel Pharma and Third Rock Ventures, with participation from Bain Capital Life Sciences, GV (Google Ventures), QVT, and Pictet. Surfaced in the API Evangelist network as a portfolio company of GV. This company publishes no public API, developer, or event surface at this time.

## Kin Score — 3.3 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 3.3).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 7.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Syremis Therapeutics Domain Security** — TLSv1.3

## Tags

Company, Life Sciences, Biotechnology, Pharmaceuticals, Mental Health, Neuroscience, Drug Discovery

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/syremis-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.